⌘K

Login Start Free

Home/Filings/4/0001209191-23-016362

4//SEC Filing

Eisner Mark 4

Accession 0001209191-23-016362

CIK 0000921299other

View on SEC.gov Company Profile

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:59 PM ET

Size

4.7 KB

Accession

0001209191-23-016362

Insider Transaction Report

Form 4

Period: 2023-03-02

FIBROGEN INCFGEN

Incoming Chief Medical Officer

Transactions

Sale
Common Stock
2023-03-02$21.87/sh−1,187$25,960→ 172,496 total

Footnotes (1)

[F1]Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

FIBROGEN INC

CIK 0000921299

Entity typeother

Related Parties

1

filerCIK 0001834161

Filing Metadata

Form type: 4
Filed: Mar 5, 7:00 PM ET
Accepted: Mar 6, 4:59 PM ET
Size: 4.7 KB

View on SEC.gov